{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:57:43Z","timestamp":1782500263504,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12664-021-01211-6","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T09:02:42Z","timestamp":1628931762000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Small intestinal bacterial overgrowth in patients with inflammatory bowel disease: A case-control study"],"prefix":"10.1007","volume":"41","author":[{"given":"Uday C.","family":"Ghoshal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand Prakash","family":"Agrahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,14]]},"reference":[{"key":"1211_CR1","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769\u201378.","journal-title":"Lancet"},{"key":"1211_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13099-021-00426-4","volume":"13","author":"E Mahmoudi","year":"2021","unstructured":"Mahmoudi E, Mozhgani SH, Sharifinejad N. The role of mycobiota-genotype association in inflammatory bowel diseases: a narrative review. Gut Pathog. 2021;13:31.","journal-title":"Gut Pathog"},{"key":"1211_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/apt.15133","volume":"49","author":"A Shah","year":"2019","unstructured":"Shah A, Morrison M, Burger D, et al. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Aliment Pharmacol Ther. 2019;49:624\u201335.","journal-title":"Aliment Pharmacol Ther"},{"key":"1211_CR4","doi-asserted-by":"crossref","unstructured":"Franzin M, Stefan\u010di\u010d K, Lucaf\u00f2 M, Decorti G, Stocco G. Microbiota and drug response in inflammatory bowel disease. Pathogens. 2021;10:211.","DOI":"10.3390\/pathogens10020211"},{"key":"1211_CR5","doi-asserted-by":"crossref","unstructured":"Aldars-Garc\u00eda L, Chaparro M, Gisbert JP. Systematic review: the gut microbiome and its potential clinical application in inflammatory bowel disease. Microorganisms. 2021;9:977.","DOI":"10.3390\/microorganisms9050977"},{"key":"1211_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.gtc.2016.09.008","volume":"46","author":"UC Ghoshal","year":"2017","unstructured":"Ghoshal UC, Ghoshal U. Small intestinal bacterial overgrowth and other intestinal disorders. Gastroenterol Clin North Am. 2017;46:103\u201320.","journal-title":"Gastroenterol Clin North Am"},{"key":"1211_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5056\/jnm.2011.17.3.312","volume":"17","author":"UC Ghoshal","year":"2011","unstructured":"Ghoshal UC. How to interpret hydrogen breath tests. J Neurogastroenterol Motil. 2011;17:312\u20137.","journal-title":"J Neurogastroenterol Motil"},{"key":"1211_CR8","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jgh.14938","volume":"35","author":"UC Ghoshal","year":"2020","unstructured":"Ghoshal UC, Nehra A, Mathur A, Rai S. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome. J Gastroenterol Hepatol. 2020;35:922\u201331.","journal-title":"J Gastroenterol Hepatol"},{"key":"1211_CR9","unstructured":"Agrawal M, Spencer EA, Colombel JF, Ungaro RC. \u00a0 Approach to the management of recently diagnosed inflammatory bowel disease patients: a user\u2019s guide for adult and pediatric gastroenterologists. \u00a0 Gastroenterology. 2021:S0016-5085(21)00734-4."},{"key":"1211_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12664-017-0804-y","volume":"36","author":"S Kedia","year":"2017","unstructured":"Kedia S, Sharma R, Makharia GK, et al. Imaging of the small intestine in Crohn's disease: joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association. Indian J Gastroenterol. 2017;36:487\u2013508.","journal-title":"Indian J Gastroenterol"},{"key":"1211_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.disamonth.2017.07.001","volume":"64","author":"M Gajendran","year":"2018","unstructured":"Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn ' s disease. Dis Mon. 2018;64:20\u201357.","journal-title":"Dis Mon"},{"key":"1211_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3748\/wjg.v25.i4.418","volume":"25","author":"S Kedia","year":"2019","unstructured":"Kedia S, Das P, Madhusudhan KS, et al. Differentiating Crohn ' s disease from intestinal tuberculosis. World J Gastroenterol. 2019;25:418\u201332.","journal-title":"World J Gastroenterol"},{"key":"1211_CR13","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1007\/s10620-009-0826-0","volume":"55","author":"CP Lakshmi","year":"2010","unstructured":"Lakshmi CP, Ghoshal UC, Kumar S, et al. Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction. Dig Dis Sci. 2010;55:1142\u20138.","journal-title":"Dig Dis Sci"},{"key":"1211_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.gtc.2020.08.003","volume":"49","author":"BS Pabla","year":"2020","unstructured":"Pabla BS, Schwartz DA. Assessing severity of disease in patients with ulcerative colitis. Gastroenterol Clin North Am. 2020;49:671\u201388.","journal-title":"Gastroenterol Clin North Am"},{"key":"1211_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/jgh3.12342","volume":"4","author":"UC Ghoshal","year":"2020","unstructured":"Ghoshal UC, Rai S, Kulkarni A, Gupta A. Prediction of outcome of treatment of acute severe ulcerative colitis using principal component analysis and artificial intelligence. JGH Open. 2020;4:889\u201397.","journal-title":"JGH Open"},{"key":"1211_CR16","first-page":"2349","volume":"14","author":"J Demsar","year":"2013","unstructured":"Demsar J, Curk T, Erjavec A, et al. Orange: data mining toolbox in python. Journal of Machine Learning Research. 2013;14:2349\u201353.","journal-title":"Journal of Machine Learning Research"},{"key":"1211_CR17","doi-asserted-by":"crossref","unstructured":"Rutgeerts P, Ghoos Y, Vantrappen G, Eyssen H. Ileal dysfunction and bacterial overgrowth in patients with Crohn\u2019s disease. Eur J Clin Invest. 1981;11:199\u2013206.","DOI":"10.1111\/j.1365-2362.1981.tb01841.x"},{"key":"1211_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00004836-200007000-00015","volume":"31","author":"F Castiglione","year":"2000","unstructured":"Castiglione F, Del Vecchio BG, Rispo A, et al. Orocecal transit time and bacterial overgrowth in patients with Crohn\u2019s disease. J Clin Gastroenterol. 2000;31:63\u20136.","journal-title":"J Clin Gastroenterol"},{"key":"1211_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1046\/j.1365-2036.2003.01800.x","volume":"18","author":"F Castiglione","year":"2003","unstructured":"Castiglione F, Rispo A, Di Girolamo E, et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2003;18:1107\u201312.","journal-title":"Aliment Pharmacol Ther"},{"key":"1211_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1023\/A:1017991313789","volume":"47","author":"D Mishkin","year":"2002","unstructured":"Mishkin D, Boston FM, Blank D, Yalovsky M, Mishkin S. The glucose breath test: a diagnostic test for small bowel stricture(s) in Crohn\u2019s disease. Dig Dis Sci. 2002;47:489\u201394. \u00a0","journal-title":"Dig Dis Sci"},{"key":"1211_CR21","doi-asserted-by":"crossref","unstructured":"Sanchez-Montes C, Ortiz V, Bastida G, et al. Small intestinal bacterial overgrowth in inactive Crohn's disease: influence of thiopurine and biological treatment. World J Gastroenterol. 2014;20:13999\u20134003.","DOI":"10.3748\/wjg.v20.i38.13999"},{"key":"1211_CR22","doi-asserted-by":"crossref","unstructured":"Klaus J, Spaniol U, Adler G, Mason RA, Reinshagen M, von Tirpitz C C. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's disease. BMC Gastroenterol. 2009;9:61.","DOI":"10.1186\/1471-230X-9-61"},{"key":"1211_CR23","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.crohns.2014.01.007","volume":"8","author":"SV Rana","year":"2014","unstructured":"Rana SV, Sharma S, Kaur J, et al. Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients. J Crohns Colitis. 2014;8:859\u201365.","journal-title":"J Crohns Colitis"},{"key":"1211_CR24","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1007\/s10620-013-2694-x","volume":"58","author":"SV Rana","year":"2013","unstructured":"Rana SV, Sharma S, Malik A, et al. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease. Dig Dis Sci. 2013;58:2594\u20138.","journal-title":"Dig Dis Sci"},{"key":"1211_CR25","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/jgh.12908","volume":"30","author":"JM Lee","year":"2015","unstructured":"Lee JM, Lee KM, Chung YY, et al. Clinical significance of the glucose breath test in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2015;30:990\u20134.","journal-title":"J Gastroenterol Hepatol"},{"key":"1211_CR26","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3109\/00365521.2015.1050691","volume":"50","author":"A Greco","year":"2015","unstructured":"Greco A, Caviglia GP, Brignolo P, et al. Glucose breath test and Crohn's disease: diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response. Scand J Gastroenterol. 2015;50:1376\u201381.","journal-title":"Scand J Gastroenterol"},{"key":"1211_CR27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/MCG.0000000000000803","volume":"52","author":"JERJ Ricci","year":"2018","unstructured":"Ricci JERJ, Chebli LA, Ribeiro T, et al. Small-intestinal bacterial overgrowth is associated with concurrent intestinal inflammation but not with systemic inflammation in Crohn\u2019s disease patients. J Clin Gastroenterol. 2018;52:530\u20136.","journal-title":"J Clin Gastroenterol"},{"key":"1211_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5009\/gnl16126","volume":"11","author":"UC Ghoshal","year":"2017","unstructured":"Ghoshal UC, Shukla R, Ghoshal U. Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy. Gut Liver. 2017;11:196\u2013208.","journal-title":"Gut Liver"},{"key":"1211_CR29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/17474124.2019.1671822","volume":"13","author":"EF Stange","year":"2019","unstructured":"Stange EF, Schroeder BO. Microbiota and mucosal defense in IBD: an update. Expert Rev Gastroenterol Hepatol. 2019;13:963\u201376.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1211_CR30","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ibd.22876","volume":"18","author":"T Inoue","year":"2012","unstructured":"Inoue T, Iijima H, Tajiri M, et al. Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn\u2019s disease. Inflamm Bowel Dis. 2012;18:1723\u201334.","journal-title":"Inflamm Bowel Dis"},{"key":"1211_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12664-020-01114-y","volume":"40","author":"JSY Tam","year":"2021","unstructured":"Tam JSY, Coller JK, Hughes PA, Prestidge CA, Bowen JM. Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation. Indian J Gastroenterol. 2021;40:5\u201321. \u00a0","journal-title":"Indian J Gastroenterol"},{"key":"1211_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coph.2020.08.009","volume":"55","author":"C Haifer","year":"2020","unstructured":"Haifer C, Leong RW, Paramsothy S. The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease. Curr Opin Pharmacol. 2020;55:8\u201316.","journal-title":"Curr Opin Pharmacol"},{"key":"1211_CR33","doi-asserted-by":"publisher","first-page":"104344","DOI":"10.1016\/j.phrs.2019.104344","volume":"148","author":"M Shamoon","year":"2019","unstructured":"Shamoon M, Martin NM, O\u2019Brien CL. Recent advances in gut microbiota mediated therapeutic targets in inflammatory bowel diseases: emerging modalities for future pharmacological implications. Pharmacol Res. 2019;148:104344.","journal-title":"Pharmacol Res"},{"key":"1211_CR34","doi-asserted-by":"publisher","first-page":"103774","DOI":"10.1016\/j.micpath.2019.103774","volume":"137","author":"I Aggeletopoulou","year":"2019","unstructured":"Aggeletopoulou I, Konstantakis C, Assimakopoulos SF, Triantos C. The role of the gut microbiota in the treatment of inflammatory bowel diseases. Microb Pathog. 2019;137:103774.","journal-title":"Microb Pathog"},{"key":"1211_CR35","doi-asserted-by":"crossref","unstructured":"Tibdewal P, Bhatt P, Jain A, Gupta D, Bhatia S, Shukla A. Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India. Indian J Gastroenterol. 2019;38:295\u2013302. \u00a0","DOI":"10.1007\/s12664-019-00968-1"},{"key":"1211_CR36","doi-asserted-by":"publisher","first-page":"814","DOI":"10.14309\/ajg.0000000000000604","volume":"115","author":"A Shah","year":"2020","unstructured":"Shah A, Macdonald GA, Morrison M, Holtmann G. Targeting the gut microbiome as a treatment for primary sclerosing cholangitis: a conceptional framework. Am J Gastroenterol. 2020;115:814\u201322.","journal-title":"Am J Gastroenterol"},{"key":"1211_CR37","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2174\/1389450120666190723130137","volume":"20","author":"C Benlice","year":"2019","unstructured":"Benlice C, Shen B, Steele SR. Prevention and medical treatment of pouchitis in ulcerative colitis. Curr Drug Targets. 2019;20:1399\u2013408.","journal-title":"Curr Drug Targets"},{"key":"1211_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/MEG.0000000000000557","volume":"28","author":"UC Ghoshal","year":"2016","unstructured":"Ghoshal UC, Srivastava D, Misra A, Ghoshal U. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial. Eur J Gastroenterol Hepatol. 2016;28:281\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1211_CR39","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.14309\/ajg.0000000000000444","volume":"114","author":"A Rezaie","year":"2019","unstructured":"Rezaie A, Heimanson Z, McCallum R, Pimentel M. Lactulose breath testing as a predictor of response to rifaximin in patients with irritable bowel syndrome with diarrhea. Am J Gastroenterol. 2019;114:1886\u201393.","journal-title":"Am J Gastroenterol"},{"key":"1211_CR40","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/nmo.12331","volume":"26","author":"J Zhao","year":"2014","unstructured":"Zhao J, Zheng X, Chu H, et al. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients. Neurogastroenterol Motil. 2014;26:794\u2013802.","journal-title":"Neurogastroenterol Motil"},{"key":"1211_CR41","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.addr.2004.08.007","volume":"57","author":"U Klotz","year":"2005","unstructured":"Klotz U, Schwab M. Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv Drug Deliv Rev. 2005;57:267\u201379.","journal-title":"Adv Drug Deliv Rev"},{"key":"1211_CR42","first-page":"95","volume":"29","author":"UC Ghoshal","year":"2008","unstructured":"Ghoshal UC, Shukla A. Malnutrition in inflammatory bowel disease patients in northern India: frequency and factors influencing its development. Trop Gastroenterol. 2008;29:95\u20137.","journal-title":"Trop Gastroenterol"},{"key":"1211_CR43","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12664-019-00976-1","volume":"38","author":"A Sood","year":"2019","unstructured":"Sood A, Ahuja V, Kedia S, et al. Diet and inflammatory bowel disease: the Asian Working Group guidelines. Indian J Gastroenterol. 2019;38:220\u201346.","journal-title":"Indian J Gastroenterol"},{"key":"1211_CR44","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/MEG.0000000000000122","volume":"26","author":"UC Ghoshal","year":"2014","unstructured":"Ghoshal UC, Srivastava D, Ghoshal U, Misra A. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Eur J Gastroenterol Hepatol. 2014;26:753\u201360.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1211_CR45","first-page":"6","volume":"25","author":"UC Ghoshal","year":"2006","unstructured":"Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol. 2006;25:6\u201310.","journal-title":"Indian J Gastroenterol"},{"key":"1211_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5056\/jnm19113","volume":"26","author":"G Losurdo","year":"2020","unstructured":"Losurdo G, Leandro G, Ierardi E, et al. Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: a systematic review with meta-analysis. J Neurogastroenterol Motil. 2020;26:16\u201328.","journal-title":"J Neurogastroenterol Motil"},{"key":"1211_CR47","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12664-017-0797-6","volume":"36","author":"UC Ghoshal","year":"2017","unstructured":"Ghoshal UC, Baba CS, Ghoshal U, et al. Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture. Indian J Gastroenterol. 2017;36:390\u20139.","journal-title":"Indian J Gastroenterol"},{"key":"1211_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12664-020-01027-w","volume":"39","author":"UC Ghoshal","year":"2020","unstructured":"Ghoshal UC, Goel A, Quigley EMM. Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: an emerging paradigm. Indian J Gastroenterol. 2020;39:9\u201321.","journal-title":"Indian J Gastroenterol"},{"key":"1211_CR49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ajg.2017.46","volume":"112","author":"A Rezaie","year":"2017","unstructured":"Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112:775\u201384.","journal-title":"Am J Gastroenterol"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-021-01211-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-021-01211-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-021-01211-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T05:36:00Z","timestamp":1649741760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-021-01211-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,14]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1211"],"URL":"https:\/\/doi.org\/10.1007\/s12664-021-01211-6","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,14]]},"assertion":[{"value":"26 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"U. C. G. is the sole patent applicant for the Ghoshal BreathCalc (No. 202111029055). AY, BF, APA, and AM have any conflict of interest to declare in relation to this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed conforming to the Helsinki declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com. Waiver from the Ethics Committee of the Sanjay Gandhi Postgraduate Institute of Medical Sciences was obtained (No. 2021-153-DM-EXP-39; PGI\/BE\/1364\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer\/publishers are responsible for the results\/findings and content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}